https://sputnikglobe.com/20261113/russian-pharmaceutical-company-promomed-opens-research-division-in-china-1125069350.html
Russian Pharmaceutical Company PROMOMED Opens Research Division in China
Russian Pharmaceutical Company PROMOMED Opens Research Division in China
Sputnik International
PROMOMED opened a new division at the Russian Trade Representation in China on November 13, focusing on joint drug development, molecular research, and clinical trials.
2026-11-13T14:22+0000
2026-11-13T14:22+0000
2026-11-13T14:22+0000
world
china
russia
pharmaceuticals
research
patients
doctors
medicine
https://cdn.imgsputnikglobe.com/img/07ea/0b/0d/1125069062_2:0:1686:947_1920x0_80_0_0_a1c012a24a4b9947a45f983c1fed7def.png
Company chairman and co-owner Pyotr Bely told Sputnik that the initiative would support the exchange of pharmaceutical developments between Russia and China, bringing new treatments to doctors and patients in both countries.
https://sputnikglobe.com/20261110/russia-ranks-as-chinas-5th-largest-trading-partner---customs-data-1125038827.html
china
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Russian pharmaceutical company PROMOMED opens research division in China
Sputnik International
Russian pharmaceutical company PROMOMED opens research division in China
2026-11-13T14:22+0000
true
PT3M40S
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
china, russia, pharmaceuticals, research, patients, doctors, medicine
china, russia, pharmaceuticals, research, patients, doctors, medicine
Russian Pharmaceutical Company PROMOMED Opens Research Division in China
PROMOMED opened a new division at the Russian Trade Representation in China on November 13, focusing on joint drug development, molecular research, and clinical trials.
Company chairman and co-owner Pyotr Bely told Sputnik that the initiative would support the exchange of pharmaceutical developments between
Russia and China, bringing new treatments to doctors and patients in both countries.
